Healthcare
from24/7 Wall St.
18 hours agoXLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500
XLV provides concentrated U.S. healthcare exposure with heavy mega-cap weighting, low costs, and growth orientation but higher single-sector concentration risk.